DGIST's research team, led by Dr. Yun-Il Lee in Well Aging Research Center, has identified a new mechanism to inhibit dopaminergic neuronal apoptosis, a possible approach for preventing and treating Parkinson's disease (PD).
Nov 9, 2017
0
20
A growing collection of anecdotal stories raises the possibility that nerve injury in an arm or a leg can act as a trigger for the development amyotrophic lateral sclerosis, or ALS—a progressive neurodegenerative disease ...
Feb 20, 2019
0
648
There are no approved drugs to treat nonalcoholic fatty liver disease but controlling blood sugar over time may help decrease the risk of liver scarring and disease progression.
May 19, 2021
0
14
A new study co-led by scientists at the La Jolla Institute for Immunology (LJI) adds increasing evidence that Parkinson's disease is partly an autoimmune disease. In fact, the researchers report that signs of autoimmunity ...
Apr 20, 2020
0
341
The number of new COVID-19 cases continues to rise in many parts of the world, with the highest incidence in the United States.
Feb 9, 2021
0
105
One of the hallmarks of Parkinson's disease (PD) is the accumulation in the brain of a protein known as alpha-synuclein. For more than two decades, alpha-synuclein has been a focal point of attention for researchers, clinicians ...
Jun 9, 2022
0
78
Patients suffering REM sleep behaviour disorders dream nightmares in which they are attacked and pursued, with the particularity that they express them by screaming, crying, punching and kicking while sleeping. Lancet Neurology ...
Jul 29, 2011
0
0
Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the University of Glasgow.
May 20, 2019
0
145
Enhanced cholesterol metabolism in certain immune cells may help some people infected with HIV naturally control disease progression, according to new research from the University of Pittsburgh Graduate School of Public Health.
Jul 17, 2015
0
112
An anti-viral gene that impacts the risk of both Alzheimer's disease and severe COVID-19 has been identified by a UCL-led research team.
Oct 8, 2021
0
232
